sulfamethizole has been researched along with ciprofloxacin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 7 (58.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Brittain, DC; Labthavikul, P; McElrath, MJ; Neu, HC; Scully, BE; Steinman, R | 1 |
| Dekker, AW; Rozenberg-Arska, M; Verhoef, J | 1 |
| Depta, JP; Lüthi, M; Pichler, WJ; Schmid, DA | 1 |
| Anderson, G; Call, V; Foley, SL; Kaldhone, P; Kerdahi, K; Nayak, R; Phillips, S; Tyler, C | 1 |
| Biesiada, G; Czepiel, J; Garlicki, A; Mach, T; Salamon, D; Skwara, P; Sobczyk-Krupiarz, I | 1 |
| Kadlec, MW; Liao, JC; Wong, PK; You, D | 1 |
| Alpay, H; Altuntaş, Ü; Bıyıklı, N; Çiçek, N; Gökçe, İ; Güven, S; Yıldız, N | 1 |
| Cattrall, JWS; Kirby, A; Robinson, AV | 1 |
2 review(s) available for sulfamethizole and ciprofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Combinations; Humans; Norfloxacin; Pyelonephritis; Randomized Controlled Trials as Topic; Sulfamethizole; Trimethoprim | 2018 |
2 trial(s) available for sulfamethizole and ciprofloxacin
| Article | Year |
|---|---|
The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Bacteriuria; Blood Bactericidal Activity; Ciprofloxacin; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Gram-Negative Bacteria; Humans; Kinetics; Male; Quinolines; Random Allocation; Sulfamethizole; Time Factors; Trimethoprim | 1985 |
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Colistin; Drug Combinations; Drug Resistance, Microbial; Humans; Leukemia; Leukemia, Lymphoid; Patient Compliance; Random Allocation; Sulfamethizole; Sulfathiazoles; Trimethoprim | 1987 |
8 other study(ies) available for sulfamethizole and ciprofloxacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Transfection of drug-specific T-cell receptors into hybridoma cells: tools to monitor drug interaction with T-cell receptors and evaluate cross-reactivity to related compounds.
Topics: Animals; B-Lymphocytes; CD3 Complex; CD4 Antigens; Cell Line, Transformed; Cells, Cultured; Ciprofloxacin; Cross Reactions; Drug Interactions; Flow Cytometry; Humans; Hybridomas; Interleukin-2; Mice; Norfloxacin; Quinolones; Receptors, Antigen, T-Cell; Sulfamethizole; Sulfamethoxazole; Sulfanilamides; T-Lymphocytes; Time Factors; Transfection | 2006 |
Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results.
Topics: Amikacin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Chloramphenicol; Ciprofloxacin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Microbial; Gentamicins; Indicator Dilution Techniques; Microbial Sensitivity Tests; Poultry; Quality Control; Salmonella enterica; Sulfamethizole; Tetracycline; Trimethoprim | 2007 |
[A case of Salmonella paratyphi A infection in Poland].
Topics: Adult; Amoxicillin; Ceftriaxone; Ciprofloxacin; Drug Combinations; Drug Therapy, Combination; Humans; Male; Paratyphoid Fever; Salmonella paratyphi A; Sulfamethizole; Travel; Trimethoprim | 2008 |
A Cell Phone-Based Microphotometric System for Rapid Antimicrobial Susceptibility Testing.
Topics: Ampicillin; Anti-Bacterial Agents; Automation, Laboratory; Cell Phone; Chromogenic Compounds; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Humans; Lab-On-A-Chip Devices; Microarray Analysis; Microbial Sensitivity Tests; Microbial Viability; Microspectrophotometry; Oxidation-Reduction; Point-of-Care Systems; Sulfamethizole; Tetrazolium Salts; Trimethoprim; Urinary Tract Infections | 2014 |
Changes in Bacterial Resistance Patterns of Pediatric Urinary Tract Infections and Rationale for Empirical Antibiotic Therapy.
Topics: Adolescent; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cefixime; Ceftriaxone; Cefuroxime; Child; Child, Preschool; Ciprofloxacin; Community-Acquired Infections; Cross-Sectional Studies; Drug Combinations; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Humans; Infant; Male; Pediatrics; Retrospective Studies; Sulfamethizole; Trimethoprim; Turkey; Urinary Tract Infections | 2017 |